Objectives: To describe the versatility of acellular fetal bovine dermal matrix as an alternative to human cadaveric allograft for head and neck reconstructive procedures in children. Study Design: Case series with chart review. Methods: A database of pediatric operative procedures was queried for the use of acellular fetal bovine dermal matrix over a 16-month period. Indications for reconstruction were assessed and initial parental and surgeon satisfaction with the product were noted. Results: During the time period of 3/2012 and 7/2013 a total of 8 reconstructive procedures were performed on pediatric patients using acellular fetal bovine dermal matrix. Indications for use varied and included open and transnasal endoscopic repair of encephaloceles and soft tissue reconstructions including lateral pharyngeal wall repair, cleft palate repair, and facial recontouring operations. Acellular fetal bovine dermal matrix had a subjectively increased ease of use as compared to the surgeon's prior experience with human cadaveric acellular dermis. Every parent vocalized a greater comfort level with the use of a bovine product over the alternative of human cadaveric tissue. The cost of acellular fetal bovine dermal matrix is slightly lower than the cost of human cadaveric acellular dermis. Conclusions: Acellular fetal bovine dermal matrix appears to be an acceptable alternative to human cadaveric acellular dermis for various forms of head and neck soft tissue reconstruction in children. Further prospective studies are warranted to assess for any differences in the long-term efficacy of this product as compared to other forms of allograft reconstruction.
Introduction
The field of pediatric head and neck reconstruction continues to evolve. There is a growing armamentarium of techniques and materials available to the reconstructive surgeon, with the introduction of injectable fillers and biological products continuing outpace research into the safety and efficacy of these modalities in children. Additionally, application of the endoscope has allowed for the transition from open to endoscopic approaches to pediatric skull base repair using techniques that rely on a variety of materials including tissue glues, allogeneic implants, autografts, and mucosal grafts or flaps [1] . Human cadaveric dermal matrices have found broad application in reconstructive head and neck surgery, including use in septoplasty, parotidectomy, and oral cavity reconstruction [2] - [5] . The use of human cadaveric acellular dermal allograft (AlloDerm, LifeCell, Bridgewater, NJ) has become standard practice in many forms of pediatric soft tissue and skull base repair [6] - [9] . In skull base reconstruction this product is generally used as an in-lay graft as part of a multilayered closure; many different nuances of application have been described [10] - [13] . The relative advantages of allograft reconstruction may include product availability, ease of endoscopic tissue manipulation, and avoidance of donor site morbidity (relative to autologous tissue).
Recently a new biological product, acellular fetal bovine dermal matrix (SurgiMend, TEI Biosciences, Waltham, MA), was approved by the Food and Drug Administration as a medical device. Acellular fetal bovine dermal matrix is comprised of tissue that has been terminally sterilized, with theoretical disease transmission risk that is favorable compared to human cadaveric dermis. This product has been applied in wound closure in both cosmetic and general surgery procedures in both adults and children [14] [15] . We recently presented three cases comprising our initial experience using this product for pediatric skull base reconstruction [16] . Within this present series we report on our growing experience using acellular fetal bovine dermal matrix for endoscopic and open pediatric head and neck reconstruction.
Materials and Methods
After institutional review board approval was obtained, a database of pediatric operative procedures was queried for the use of fetal bovine derived acellular dermal matrix over a 16-month period (3/2012 to 7/2013). Indications for soft tissue reconstruction were assessed and initial parental and surgeon satisfaction with the product were noted.
Results
Eight patients were identified. Indications for allograft reconstruction included congenital and post-traumatic encephalocele repair and head and neck soft tissue reconstructions (lateral pharyngeal wall repair, cleft palate repair, and facial recontouring procedures). Case descriptions and outcomes are summarized in Table 1 .
Three patients had undergone anterior or lateral skull base reconstruction ( Figure 1 ) and three additional cases involved the use of acellular fetal bovine dermal matrix to provide improved contouring of facial defects or scars. In these cases the dermal matrix was placed in the subdermal or subperiosteal plane to address depressed scar or atrophic dermis and soft tissue (Figure 2) .
There was one case in which the matrix was used in an underlay fashion to prevent oronasal fistula formation in the context of a primary palatoplasty for closure of a wide cleft palate. The width of the cleft was wider than the width of the oral mucoperiosteal flaps in this case, preventing a proper multilayer closure along the lateral edges of the medially-advanced oral flaps. Additionally a small tear had occurred laterally during mobilization of the nasal mucoperiosteal flap on one side (Figure 3) .
In the final case, the dermal matrix was used to repair a lateral pharyngeal wall defect, which could not be closed primarily due to excessive tension on the wound. The purpose of using a dermal matrix for repair in this case was to provide a scaffold for epithelial in growth while protecting the parapharygeal fat and carotid sheath from desiccation and gross contamination with oral flora.
Fetal bovine derived acellular dermal matrix had a subjectively increased ease of use in regards to tissue handling as compared to the surgeon's prior experience with human cadaveric acellular dermis. Additionally, every parent vocalized a greater comfort level with the use of a bovine product over the alternative of irradiated, human cadaveric tissue. Acellular fetal bovine dermal matrices are available in a wider variety of graft thicknesses when compared to available human cadaveric products that are currently available, and the cost of fetal bovine derived acellular dermal matrix is lower than human cadaveric products ( Table 2 ).
Discussion
Human acellular dermal matrix has been accepted as a useful product in pediatric soft tissue reconstruction and the endoscopic repair of skull base defects [6] - [9] . There are several reasons why acellular fetal bovine dermal matrix may be superior to human cadaveric tissue for soft tissue and skull base reconstruction. First, acellular fetal bovine dermal matrix is more pliable than human cadaveric tissue and easier to work with in tight spaces (e.g. a tight tissue pocket or endoscopically). In addition to inherent tissue characteristics that make this allograft more pliable than other options, it is available in variable 1, 2, 3, or 4 mm thicknesses. These details can be important when performing surgery on children at various stages of development. Second, acellular fetal bovine dermal matrix is available at a lower cost when compared to human tissue products. A recent review of dermal allografts found acellular fetal bovine dermal matrix to be one of the least costly products available, with an estimated cost of 23 dollars/cm 2 as compared to 28 -35 dollars/cm 2 for human cadaveric dermal products [14] [15] . Finally, acellular fetal bovine dermal matrix is classified as a medical device rather than a tissue product. While cadaveric allografts are sterilized and irradiated to eradicate communicable disease, some patients (especially parents of infants and children) are uncomfortable with the use of a human tissue product from an anonymous donor. In our initial experience, parents are more comfortable with the concept of sterilized xenografts than implanted human cadaveric allografts.
Although there are no prior studies on the use of this product in pediatric head and neck or skull base reconstruction, it has been relatively well-studied in other fields. Acellular fetal bovine dermal matrix was first developed for use in pediatric inguinal hernia reconstruction [14] . Currently, the most well documented application of this product has been in breast reconstruction. Butterfield et al. recently published a review of over 400 cases performed with either acellular fetal bovine dermal matrix or human cadaveric dermal products. This study found a higher rate of postoperative seroma in the cases with human cadaveric dermal matrix, although statistical significance was not achieved [15] . 
Conclusion
Acellular fetal bovine dermal matrix (SurgiMend) may be a comparable material to human cadaveric acellular dermal matrices for pediatric head and neck and skull base reconstruction. Increased pliability, lower cost, and classification as a medical device rather than a tissue are potential advantages of this product, as compared with human cadaveric tissue. Further comparison studies are warranted.
